Elevated sales returns
Sales returns reached ₹50 crore in Q3, up 30-40% YoY, driven by excess channel inventory and weak demand. This could pressure working capital and profitability.
Insecticides (India) · risk themes across the available quarters.
Bear-case history
Sales returns reached ₹50 crore in Q3, up 30-40% YoY, driven by excess channel inventory and weak demand. This could pressure working capital and profitability.
The ban on Monocrotophos (final year) will result in a loss of ~₹70 crore gross sales, which may not be fully offset by new products.
Chinese agrochemical prices remain near two-decade lows, and any further depreciation of the rupee could intensify pricing pressure on domestic players.
Higher reliance on B2B sales (lower margin) to achieve topline targets is compressing gross margins, with management unable to quantify the impact.
Management noted that geopolitical issues have increased raw material prices by up to 10%, which could pressure margins if not passed through.
May was sluggish due to heatwaves; management admitted that June monsoon performance is critical for kharif season demand.
An analyst questioned whether Kyros would create channel conflict with existing IIL distributors; management downplayed but acknowledged initial reservations.
Finance costs more than doubled to ₹16.87 cr in FY26 due to higher inventory and new product investments; management targets reduction but no guarantee.